Correlation
The correlation between MKGAF and TMO is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
MKGAF vs. TMO
Compare and contrast key facts about Merck KGaA (MKGAF) and Thermo Fisher Scientific Inc. (TMO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MKGAF or TMO.
Performance
MKGAF vs. TMO - Performance Comparison
Loading data...
Key characteristics
MKGAF:
-0.54
TMO:
-1.04
MKGAF:
-0.33
TMO:
-1.59
MKGAF:
0.96
TMO:
0.81
MKGAF:
-0.39
TMO:
-0.73
MKGAF:
-0.90
TMO:
-1.82
MKGAF:
22.43%
TMO:
16.20%
MKGAF:
48.16%
TMO:
27.26%
MKGAF:
-51.99%
TMO:
-71.16%
MKGAF:
-45.44%
TMO:
-39.12%
Fundamentals
MKGAF:
$56.85B
TMO:
$152.41B
MKGAF:
$7.41
TMO:
$17.00
MKGAF:
18.29
TMO:
23.70
MKGAF:
1.49
TMO:
1.55
MKGAF:
2.67
TMO:
3.55
MKGAF:
1.76
TMO:
3.08
MKGAF:
$21.32B
TMO:
$42.90B
MKGAF:
$12.62B
TMO:
$17.83B
MKGAF:
$4.54B
TMO:
$10.60B
Returns By Period
In the year-to-date period, MKGAF achieves a -9.09% return, which is significantly higher than TMO's -22.50% return. Over the past 10 years, MKGAF has underperformed TMO with an annualized return of 3.74%, while TMO has yielded a comparatively higher 12.34% annualized return.
MKGAF
-9.09%
-5.83%
-4.82%
-25.17%
-8.91%
5.99%
3.74%
TMO
-22.50%
-4.07%
-23.82%
-28.87%
-10.57%
3.15%
12.34%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MKGAF vs. TMO — Risk-Adjusted Performance Rank
MKGAF
TMO
MKGAF vs. TMO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck KGaA (MKGAF) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
MKGAF vs. TMO - Dividend Comparison
MKGAF's dividend yield for the trailing twelve months is around 1.67%, more than TMO's 0.40% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MKGAF Merck KGaA | 1.67% | 1.55% | 1.50% | 1.03% | 0.65% | 0.85% | 1.20% | 1.48% | 1.21% | 1.14% | 1.11% | 1.37% |
TMO Thermo Fisher Scientific Inc. | 0.40% | 0.30% | 0.26% | 0.22% | 0.16% | 0.19% | 0.23% | 0.30% | 0.32% | 0.43% | 0.42% | 0.48% |
Drawdowns
MKGAF vs. TMO - Drawdown Comparison
The maximum MKGAF drawdown since its inception was -51.99%, smaller than the maximum TMO drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for MKGAF and TMO.
Loading data...
Volatility
MKGAF vs. TMO - Volatility Comparison
Merck KGaA (MKGAF) has a higher volatility of 12.88% compared to Thermo Fisher Scientific Inc. (TMO) at 11.65%. This indicates that MKGAF's price experiences larger fluctuations and is considered to be riskier than TMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
MKGAF vs. TMO - Financials Comparison
This section allows you to compare key financial metrics between Merck KGaA and Thermo Fisher Scientific Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MKGAF vs. TMO - Profitability Comparison
MKGAF - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Merck KGaA reported a gross profit of 3.15B and revenue of 5.28B. Therefore, the gross margin over that period was 59.6%.
TMO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Thermo Fisher Scientific Inc. reported a gross profit of 4.24B and revenue of 10.36B. Therefore, the gross margin over that period was 40.9%.
MKGAF - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Merck KGaA reported an operating income of 1.01B and revenue of 5.28B, resulting in an operating margin of 19.1%.
TMO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Thermo Fisher Scientific Inc. reported an operating income of 1.72B and revenue of 10.36B, resulting in an operating margin of 16.6%.
MKGAF - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Merck KGaA reported a net income of 735.00M and revenue of 5.28B, resulting in a net margin of 13.9%.
TMO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Thermo Fisher Scientific Inc. reported a net income of 1.51B and revenue of 10.36B, resulting in a net margin of 14.5%.